Fifteen years ago, in the mysterious land of Toronto, Canada, Scott Pilgrim was a box office failure. Now it's a cult favorite with a Netflix anime and an upcoming video game sequel.

Gilead Sciences' cell therapy unit Kite has reached an agreement to buy Interius BioTherapeutics, bolstering its efforts to develop therapies that do not require cells to be removed from the body ...